This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Parents should be reassured that children with febrile seizures have an excellent outcome (in the absence of underlying developmental problems)

  • UK population based study reported that children with febrile seizures (287 simple and 94 complex febrile seizure patients) performed as well as other children in terms of their academic progress, intellectual function, and behaviour at 10 years of age.
  • population based cohort study in Rotterdam carried out in 2012 reported that
    • there was no increased risk of behavioural difficulties or problems in executive functioning in children with febrile seizures
    • in recurrent febrile seizures, patients had an increased risk of delayed language development when compared to those who had a single seizure (1)

Parents should be educated about the risk of febrile seizure recurrence.

Furthermore parents should be reassured that most children with febrile seizures (97%) will not develop epilepsy in the future (2).

Mortality from febrile seizure is difficult to calculate accurately since it is uncommon in patients with the condition (1).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.